Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-20

Clinical Trial Update: Study of the Nevisense Device to Assess Atypical Skin Lesions

View source ↗

Summary

A clinical trial evaluating the Nevisense device for assessing atypical skin lesions, including nevi, has completed; the snippet does not report trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nevisense

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Nevus, Multiple Nevi | Status: COMPLETED